Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...
As a result, growth expectations were adjusted downwards. For 2025, GDP is now expected to grow close to 4%, reflecting the carryover effect from the rebound that began in the second half of 2024, but ...
Revenue in the third quarter of 2025 marks the highest recorded quarterly revenue for the Company since 2015 and contributed to the Company’s year-to-date revenue through September 30, 2025 of ...
Major stock indexes were mixed Wednesday, with the Dow Jones Industrial Average hitting a new all-time high on optimism that ...
Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204's exceptional efficacy across multiple human cancer cell ...
Purpose/Hypothesis: Parkinson’s disease (PD) is a progressive, neurodegenerative disorder characterized by both motor and non ...
CNW/ - Thinkific Labs Inc. ("Thinkific" or the "Company") (TSX: THNC), a leading learning commerce platform, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback